EMPHASIS-lung

• Research type

  Research Study

• Full title

  A randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer who failed first line platinum based doublet chemotherapy stratified by VeriStrat Good vs VeriStrat Poor

• IRAS ID

  121765

• Contact name

  Yvonne Summers

• Contact email

  yvonne.summers@christie.nhs.uk

• Sponsor organisation

  ETOP (European Thoracic Oncology Platform)

• Eudract number

  2012-001896-35

• Clinicaltrials.gov Identifier

  NCT01652469

• REC name

  North West - Liverpool Central Research Ethics Committee

• REC reference

  13/NW/0234

• Date of REC Opinion

  8 May 2013

• REC opinion

  Further Information Favourable Opinion